Skip to content

Drug interactions

Cenobamate + Tofacitinib

Severity: Moderate

Cenobamate and Tofacitinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cenobamate inhibits CYP2C19 but also induces CYP3A4, which is the main route of tofacitinib clearance. The net effect is uncertain and could be reduced tofacitinib exposure.

What this interaction means in plain words

Cenobamate and Tofacitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Cenobamate belongs to Central Nervous System; Tofacitinib belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Cenobamate inhibits CYP2C19 and induces CYP3A4, giving opposing effects on tofacitinib metabolism.

What to do

Monitor clinical response and adverse effects when cenobamate is started or stopped. Adjust the tofacitinib dose according to response and tolerability.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cenobamate and Tofacitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Cenobamate with Tofacitinib?

MediHelp rates the interaction as moderate. Cenobamate and Tofacitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Cenobamate inhibits CYP2C19 but also induces CYP3A4, which is the main route of tofacitinib clearance. The net effect is uncertain and could be reduced tofacitinib exposure.

How serious is the interaction between Cenobamate and Tofacitinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor clinical response and adverse effects when cenobamate is started or stopped. Adjust the tofacitinib dose according to response and tolerability.

What other medicines interact with Tofacitinib?

MediHelp also lists interactions of Tofacitinib with, for example, Baricitinib, Cladribine, Upadacitinib. The full list is on the Tofacitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in